SCHEMBL872722

SCHEMBL872722

CC(O)C1C2CCC(C2)C1(C)C

nearest known ligand 0.33

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
RET P07949 1/20 0.31
MAPK14 Q16539 1/20 0.31
CAMK1D Q8IU85 1/20 0.31
UGT2B7 P16662 2/20 0.31
LMNA P02545 1/20 0.30
GPBAR1 Q8TDU6 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6535036 0.84 ALDH1A1 (0.32) ALDH1A1NPSR1
SCHEMBL11536645 0.79 UGT2B7 (0.36) ALDH1A1NPSR1UGT2B7
SCHEMBL9799218 0.77 RET (0.34) ALDH1A1NPSR1RETMAPK14CAMK1D
SCHEMBL11534418 0.77 ALDH1A1 (0.31) ALDH1A1NPSR1
SCHEMBL10889491 0.76 ACHE (0.33)
SCHEMBL11532911 0.76 ALDH1A1 (0.33) ALDH1A1NPSR1
SCHEMBL7546802 0.75 ALDH1A1 (0.31) ALDH1A1NPSR1
SCHEMBL7545028 0.73
SCHEMBL10942651 0.73 UGT2B7 (0.42) ALDH1A1NPSR1UGT2B7
SCHEMBL11534412 0.73 ALDH1A1 (0.31) ALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3649184-A1 SILICONE COMPOUNDS The Procter and Gamble Company (US) 2020-05-13 EP claimed
EP-3649183-A1 SILICONE COMPOUNDS The Procter and Gamble Company (US) 2020-05-13 EP claimed
WO-2019010263-A1 SILICONE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2019-01-10 WO claimed
WO-2019010265-A1 SILICONE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2019-01-10 WO claimed
US-20190010293-A1 SILICONE COMPOUNDS THE PROCTER & GAMBLE COMPANY 2019-01-10 US claimed
US-20190010427-A1 SILICONE COMPOUNDS THE PROCTER & GAMBLE COMPANY 2019-01-10 US claimed
CN-117794861-A Process for producing pellets comprising magnesium ion containing material OMYA国际股份公司 2024-03-29 CN disclosed
CN-115916392-A Surface-reacted calcium carbonate in a process for producing supported microcapsules OMYA国际股份公司 2023-04-04 CN disclosed
CN-115516046-A Coating for food packaging comprising an antimicrobial active ingredient OMYA国际股份公司 2022-12-23 CN disclosed
CN-115380006-A Process for producing free-flowing granulates 欧米亚国际集团 2022-11-22 CN disclosed
CN-110891615-B System and method for selecting and releasing fragrance 阿甘香气及精细化学有限公司 2022-08-05 CN disclosed
CN-108291096-B Process for producing pellets comprising surface-reacted calcium carbonate 欧米亚国际集团 2020-06-26 CN disclosed
EP-3649184-A1 SILICONE COMPOUNDS The Procter and Gamble Company (US) 2020-05-13 EP disclosed
US-20090087401-A1 DEODORANT COMPOSITION TAKASAGO INTERNATIONAL CORPORATION (JP) 2009-04-02 US disclosed
EP-1652834-B1 Process for producing salicylic esters KAO CORP (JP) 2008-10-01 EP disclosed
EP-1707185-A1 Solvent materials and methods for preparing fragrance compositions INTERNATIONAL FLAVORS & FRAGRANCES, INC. (US) 2006-10-04 EP disclosed
US-20060165622-A1 Deodorant composition TAKASAGO INTERNATIONAL CORPORATION (JP) 2006-07-27 US disclosed
EP-1652834-A1 Process for producing salicylic esters KAO CORPORATION (JP) 2006-05-03 EP disclosed
US-20060058547-A1 Process for producing salicylic esters KAO CORPORATION (JP) 2006-03-16 US disclosed
EP-1561476-A1 DEODORANT COMPOSITION Takasago International Corporation (JP) 2005-08-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060058547-A1 Process for producing salicylic esters NOTUM, FASN, AGPS ALDH1A1 268/4885NPSR1 967/4885RET 1416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.